SNIBE(SZ:300832)2021-10-27 16:00Financial Performance - The company's revenue for Q3 2021 reached ¥668,175,059.80, an increase of 11.31% compared to the same period last year[4]. - Net profit attributable to shareholders was ¥237,105,891.00, reflecting a growth of 6.50% year-over-year[4]. - The net profit after deducting non-recurring gains and losses was ¥217,936,866.47, up by 6.09% from the previous year[4]. - In the first three quarters of 2021, the company achieved operating revenue of CNY 1,893.88 million, a year-on-year increase of 20.60%[16]. - The total profit for the same period was CNY 769.55 million, a decrease of 5.19% compared to the previous year[16]. - The net profit attributable to shareholders was CNY 665.72 million, down 4.67% year-on-year[16]. - The gross profit margin for the main business decreased by 7.93% year-on-year due to changes in sales policies and the impact of the COVID-19 pandemic[16]. - The company reported a comprehensive income total of CNY 665,588,597.10 for Q3 2021, compared to CNY 698,232,721.41 in the same period last year[52]. - Basic earnings per share decreased to CNY 0.8491 from CNY 0.9441 in the previous year, reflecting a decline of 10.1%[22]. Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥5,799,146,715.38, representing a 9.30% increase from the end of the previous year[4]. - The company's total assets reached CNY 5,799,146,715.38, up from CNY 5,305,693,720.85 at the end of 2020[51]. - The total liabilities as of the end of Q3 2021 were ¥503,959,161.18, an increase of ¥2,473,336.66 from the previous year[34]. - Total liabilities decreased to CNY 421,608,798.74 from CNY 501,485,824.52 at the end of 2020[51]. - The company's current assets totaled approximately CNY 4.29 billion, up from CNY 4.12 billion year-over-year, indicating an increase of about 4.1%[18]. - Total liabilities decreased to approximately CNY 421.61 million from CNY 501.49 million, a reduction of about 16%[19]. Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥450,740,954.91, down 35.08% compared to the same period last year[10]. - The net cash flow from operating activities decreased by 35.08% to ¥450,740,954.91, primarily due to increased inventory and employee compensation payments[40]. - Cash flow from operating activities was CNY 1,817,662,610.51, an increase from CNY 1,659,795,410.07 in the previous year[53]. - The net cash inflow from operating activities for Q3 2021 was CNY 450,740,954.91, a decrease of 35.1% compared to CNY 694,261,868.80 in the same period last year[24]. - The net cash outflow from investment activities was CNY -326,829,502.24, an improvement from CNY -2,480,170,073.66 in the previous year[24]. - The net cash flow from financing activities was CNY -284,474,973.01, a significant decrease from CNY 681,199,134.71 in Q3 2020[25]. Investments and Projects - The company has invested in new projects, with construction in progress reaching ¥311,838,003.21, an increase of 81.06%[8]. - The company reported a significant increase in long-term investments, with debt investments totaling CNY 100 million[18]. - The company reported a significant increase in other equity instrument investments, totaling ¥34,100,000.00, due to investments in specific funds[38]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 23,397[12]. - The largest shareholder, Tibet New Industry Investment Management Co., Ltd., held 26.84% of the shares, totaling 211,177,400 shares[12]. - The company has a total of 519,059,975 shares subject to restrictions, with 484,500 shares released during the reporting period[44]. Market Presence and Strategy - The company is focusing on expanding its market presence and enhancing its product offerings through ongoing research and development initiatives[20]. - The company plans to continue expanding its market presence and product offerings in response to the evolving healthcare landscape[45]. - The company served over 7,400 domestic market end customers, with 796 being top-tier hospitals, achieving a coverage rate of 50.38%[45][16].